Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21127245

Differential Involvement of Glutamatergic Mechanisms in the Cognitive and Subjective Effects of Smoking : Neurotransmission and Addiction: Recent Translational Findings

Author
JACKSON, A1 ; NESIC, J1 ; GROOMBRIDGE, C2 3 ; CLOWRY, O2 3 ; RUSTED, J4 ; DUKA, T4
[1] School of Pharmacy and Biomolecular Sciences, University of Brighton, Moulsecoomb, Brighton BN2 4GJ, United Kingdom
[2] Department of Anatomy, Brighton & Sussex Medical School, Falmer, Brighton, BN 1 9PX, United Kingdom
[3] Brighton & Sussex University Hospitals NHS Trust, The Royal Sussex County Hospital, Eastern Road, Brighton BN2 5BE, United Kingdom
[4] Department of Psychology, School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9QG, United Kingdom
Source

Neuropsychopharmacology (New York, NY). 2009, Vol 34, Num 2, pp 257-265, 9 p ; ref : 1 p.3/4

CODEN
NEROEW
ISSN
0893-133X
Scientific domain
Cognition; Neurology; Pharmacology drugs; Psychology, psychopathology, psychiatry
Publisher
Nature Publishing Group, Basingstoke
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
cognition craving mecamylamine memantine smoking subjective
Keyword (fr)
Antialzheimer Antiparkinsonien Cognition Effet psychologique Etat de manque Expérience subjective Mécamylamine Mécanisme action Mémantine Tabagisme Antagoniste Dérivé de l'amantadine Récepteur NMDA Récepteur glutamate
Keyword (en)
Antialzheimer agent Antiparkinson agent Cognition Psychological effect Craving Subjective experience Mecamylamine Mechanism of action Memantine Tobacco smoking Antagonist Amantadine derivatives NMDA receptor Glutamate receptor
Keyword (es)
Antialzheimer Antiparkinsoniano Cognición Efecto psicológico Abstinencia síndrome Experiencia subjetiva Mecamilamina Mecanismo acción Memantina Tabaquismo Antagonista Amantadina derivada Receptor NMDA Receptor glutámato
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B03 Toxicology / 002B03E Tobacco, tobacco smoking

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C05 Addictive behaviors / 002B18C05C Tobacco smoking

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03E Addictive behaviors / 770-D03E03 Tobacco smoking

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer…

Discipline
Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology Toxicology
Origin
Inist-CNRS
Database
FRANCIS ; PASCAL
INIST identifier
21127245

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web